| Year | Awards | Awarding Unit |
|---|---|---|
| 2021 | Outstanding Research Award for Junior Faculty | National Taiwan University Hospital |
| 2019 | Young Outstanding Research Award | Academic Foundation of Professor Sung Juei-Low |
| 2018 | Young Investigator Award (1st Prize), TDDW | The Gastroenterological Society of Taiwan |
| 2018 | Early Career Investigator Award, DDW | American Gastroenterological Association |
| 2018 | Travel Grant Award, The Human Microbiome Symposium | European Molecular Biology Organization |
| 2014 | Best Poster Award, THE GUT, ITS MICROBES AND HEALTH | International Life Science Institute, Singapore |
Wei-Kai Wu
Position : Assistant Professor
Office : https://www.wkwlab.com/
Phone : +886-2-3366-9314
E-mail : weikaiwu@ntu.edu.tw
Office : https://www.wkwlab.com/
Phone : +886-2-3366-9314
E-mail : weikaiwu@ntu.edu.tw
Research Expertise: Gut Microbiology/Nutritional Medicine/Human Microbiome/Nutrimicrobiomics/Next Generation Probiotics
Prof. Wei-Kai Wu is a physician-scientist specializing in gut microbiology and nutritional medicine. His research journey into the human microbiome began in 2014 since his graduate program at National Taiwan University. Throughout this period, he played a pivotal role in establishing microbiome research infrastructures at NTUH, including a germ-free mice facility and a culturomics lab. Dr. Wu has published over 50 papers in prestigious journals such as Gut, Microbiome, Clinical Nutrition, npj Biofilms and Microbiomes, Communication Biology, Seminars in Cancer Biology…etc., contributing to an impressive H-index of 23. His research endeavors primarily focus on elucidating the intricate interactions between nutrition and gut microbiota, aiming to identify personalized biomarkers and therapeutic targets for the advancement of precision medicine. Moreover, Dr. Wu is actively engaged in exploring novel strains of next-generation probiotics with the potential to mitigate a spectrum of human diseases, including cardiometabolic diseases and cancers.
Prof. Wei-Kai Wu is a physician-scientist specializing in gut microbiology and nutritional medicine. His research journey into the human microbiome began in 2014 since his graduate program at National Taiwan University. Throughout this period, he played a pivotal role in establishing microbiome research infrastructures at NTUH, including a germ-free mice facility and a culturomics lab. Dr. Wu has published over 50 papers in prestigious journals such as Gut, Microbiome, Clinical Nutrition, npj Biofilms and Microbiomes, Communication Biology, Seminars in Cancer Biology…etc., contributing to an impressive H-index of 23. His research endeavors primarily focus on elucidating the intricate interactions between nutrition and gut microbiota, aiming to identify personalized biomarkers and therapeutic targets for the advancement of precision medicine. Moreover, Dr. Wu is actively engaged in exploring novel strains of next-generation probiotics with the potential to mitigate a spectrum of human diseases, including cardiometabolic diseases and cancers.
| Ph.D. | Institute of Food Science and Technology, National Taiwan University | 2019 |
| B.S. | School of Medicine, Tzu Chi University | 2009 |
| Assistant Professor, Bachelor Program of Biotechnology and Food Nutrition, National Taiwan University | 2024-Present |
| Adjunct Research Physician, Department of Medical Research, National Taiwan University Hospital | 2024-Present |
| Research Physician, Department of Medical Research, National Taiwan University Hospital | 2020-2024 |
| Adjunct Assistant Professor, Department of Internal Medicine, National Taiwan University College of Medicine | 2020-2024 |
Years
Article
-
2024Panyod S, Wu WK, Hsieh YC, Tseng YJ, Peng SY, Chen RA, Huang HS, Chen YH, Shen TD, Ho CT, Liu CJ, Chuang HL, Huang CC, Wu MS, Sheen LY. Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice. Nutrition & Diabetes, 2024;16;14(1):65. (IF=5.0, Rank: 18.4% NUTRITION & DIETETICS) (Co-first author)
Panyod S, Wu WK, Hsieh YC, Tseng YJ, Peng SY, Chen RA, Huang HS, Chen YH, Shen TD, Ho CT, Liu CJ, Chuang HL, Huang CC, Wu MS, Sheen LY. Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice. Nutrition & Diabetes, 2024;16;14(1):65. (IF=5.0, Rank: 18.4% NUTRITION & DIETETICS) (Co-first author)
-
2024Panyod S, Wu WK, Chang CT, Wada N, Ho HC, Lo YL, Tsai SP, Chen RA, Huang HS, Liu PY, Chen YH, Chuang HL, Shen TD, Tang SL, Ho CT, Wu MS, Sheen LY. Common dietary emulsifiers promote metabolic disorders and intestinal microbiota dysbiosis in mice. Communications Biology, 2024;20;7(1):749. (IF=5.6, Rank: 11.9% BIOLOGY) (Co-first author)
Panyod S, Wu WK, Chang CT, Wada N, Ho HC, Lo YL, Tsai SP, Chen RA, Huang HS, Liu PY, Chen YH, Chuang HL, Shen TD, Tang SL, Ho CT, Wu MS, Sheen LY. Common dietary emulsifiers promote metabolic disorders and intestinal microbiota dysbiosis in mice. Communications Biology, 2024;20;7(1):749. (IF=5.6, Rank: 11.9% BIOLOGY) (Co-first author)
-
2024Wong MW, Lo IH, Wu WK, Liu PY, Yang YT, Chen CY, Wu MS, Wong SH, Lei WY, Yi CH, Liu TT, Hung JS, Liang SW, Gyawali CP, Chen CL*. Impact of Esophageal Motility on Microbiome Alterations in Symptomatic Gastroesophageal Reflux Disease Patients With Negative Endoscopy: Exploring the Role of Ineffective Esophageal Motility and Contraction Reserve. Journal of Neurogastroenterology and Motility, 2024;30(3):332-342. (IF=3.3, Rank: 28.2% CLINICAL NEUROLOGY)
Wong MW, Lo IH, Wu WK, Liu PY, Yang YT, Chen CY, Wu MS, Wong SH, Lei WY, Yi CH, Liu TT, Hung JS, Liang SW, Gyawali CP, Chen CL*. Impact of Esophageal Motility on Microbiome Alterations in Symptomatic Gastroesophageal Reflux Disease Patients With Negative Endoscopy: Exploring the Role of Ineffective Esophageal Motility and Contraction Reserve. Journal of Neurogastroenterology and Motility, 2024;30(3):332-342. (IF=3.3, Rank: 28.2% CLINICAL NEUROLOGY)
-
2024Lyu Q, Chen RA, Chuang HL, Zou HB, Liu L, Sung LK, Liu PY, Wu HY, Chang HY, Cheng WJ, Wu WK, Wu MS, Hsu CC*. Bifidobacterium alleviate metabolic disorders via converting methionine to 5'-methylthioadenosine. Gut Microbes, 2024;16(1):2300847. (IF=12.3, Rank: 5.6% MICROBIOLOGY)
Lyu Q, Chen RA, Chuang HL, Zou HB, Liu L, Sung LK, Liu PY, Wu HY, Chang HY, Cheng WJ, Wu WK, Wu MS, Hsu CC*. Bifidobacterium alleviate metabolic disorders via converting methionine to 5'-methylthioadenosine. Gut Microbes, 2024;16(1):2300847. (IF=12.3, Rank: 5.6% MICROBIOLOGY)
-
2024Hung CM, Chu WC, Huang WY, Lee PJ, Kuo WC, Hou CY, Yang CC, Yang AJ, Wu WK, Kuo ML, Wu MS, Chen WJ. Safety assessment of a proprietary fermented soybean solution, Symbiota\u00ae, as an ingredient for use in foods and dietary supplements: Non-clinical studies and a randomized trial. Food Science & Nutrition, 2024;12(4):2346-2363. (IF=3.5, Rank: 34.7% FOOD SCIENCE & TECHNOLOGY)
Hung CM, Chu WC, Huang WY, Lee PJ, Kuo WC, Hou CY, Yang CC, Yang AJ, Wu WK, Kuo ML, Wu MS, Chen WJ. Safety assessment of a proprietary fermented soybean solution, Symbiota\u00ae, as an ingredient for use in foods and dietary supplements: Non-clinical studies and a randomized trial. Food Science & Nutrition, 2024;12(4):2346-2363. (IF=3.5, Rank: 34.7% FOOD SCIENCE & TECHNOLOGY)
-
2024Panyod S, Wu WK, Hu MY, Huang HS, Chen RA, Chen YH, Shen TCD, Ho CT, Liu CJ, Chuang HL, Huang CC, Wu MS, Sheen LY. Healthy diet intervention reverses the progression of NASH through gut microbiota modulation. Microbiology Spectrum, 2024;11;12(1):e0186823. (IF=4.2, Rank: 37.9% MICROBIOLOGY) (Co-first author)
Panyod S, Wu WK, Hu MY, Huang HS, Chen RA, Chen YH, Shen TCD, Ho CT, Liu CJ, Chuang HL, Huang CC, Wu MS, Sheen LY. Healthy diet intervention reverses the progression of NASH through gut microbiota modulation. Microbiology Spectrum, 2024;11;12(1):e0186823. (IF=4.2, Rank: 37.9% MICROBIOLOGY) (Co-first author)
-
2023Lee CH, Wang CY, Kao HL, Wu WK, Kuo CH*. Differentiation of Alkyl- and Plasmenyl-phosphatidylcholine by Endogenous Sphingomyelin RT-XLOGP3 Regression for Coronary Artery Disease Plasma Lipidomics Analysis. Analytical Chemistry, 2023;21;95(46):16902-16910. (IF=6.5, Rank: 5.7% CHEMISTRY, ANALYTICAL)
Lee CH, Wang CY, Kao HL, Wu WK, Kuo CH*. Differentiation of Alkyl- and Plasmenyl-phosphatidylcholine by Endogenous Sphingomyelin RT-XLOGP3 Regression for Coronary Artery Disease Plasma Lipidomics Analysis. Analytical Chemistry, 2023;21;95(46):16902-16910. (IF=6.5, Rank: 5.7% CHEMISTRY, ANALYTICAL)
-
2023Panyod S, Wu WK, Peng SY, Tseng YJ, Hsieh YC, Chen RA, Huang HS, Chen YH, Chuang HL, Hsu CC, Shen TD, Yang KC, Ho CT, Wu MS, Sheen LY. Ginger essential oil and citral ameliorates atherosclerosis in ApoE-/- mice by modulating trimethylamine-N-oxide and gut microbiota. npj Science of Food, 2023;20;7(1):19. (IF=6.8, Rank: 9.8% FOOD SCIENCE & TECHNOLOGY) (Co-first author)
Panyod S, Wu WK, Peng SY, Tseng YJ, Hsieh YC, Chen RA, Huang HS, Chen YH, Chuang HL, Hsu CC, Shen TD, Yang KC, Ho CT, Wu MS, Sheen LY. Ginger essential oil and citral ameliorates atherosclerosis in ApoE-/- mice by modulating trimethylamine-N-oxide and gut microbiota. npj Science of Food, 2023;20;7(1):19. (IF=6.8, Rank: 9.8% FOOD SCIENCE & TECHNOLOGY) (Co-first author)
-
2023Lin MJ, Su TH, Chen CC, Wu WK, Hsu SJ, Tseng TC, Liao SH, Hong CM, Yang HC, Liu CJ, Wu MS, Kao JH. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease. Gut Pathogens, 2023;15(1):24. (IF=4.2, Rank: 20.3% GASTROENTEROLOGY & HEPATOLOGY)
Lin MJ, Su TH, Chen CC, Wu WK, Hsu SJ, Tseng TC, Liao SH, Hong CM, Yang HC, Liu CJ, Wu MS, Kao JH. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease. Gut Pathogens, 2023;15(1):24. (IF=4.2, Rank: 20.3% GASTROENTEROLOGY & HEPATOLOGY)
-
2023Huang HS, Lin YE, Panyod S, Chen RA, Lin YC, Chai LMX, Hsu CC, Wu WK, Lu KH, Huang YJ, Sheen LY. Anti-depressive-like and cognitive impairment alleviation effects of Gastrodia elata Blume water extract is related to gut microbiome remodeling in ApoE-/- mice exposed to unpredictable chronic mild stress. Journal of Ethnopharmacology, 2023;302(Pt B):115872. (IF=4.8, Rank: 9.3% INTEGRATIVE & COMPLEMENTARY MEDICINE)
Huang HS, Lin YE, Panyod S, Chen RA, Lin YC, Chai LMX, Hsu CC, Wu WK, Lu KH, Huang YJ, Sheen LY. Anti-depressive-like and cognitive impairment alleviation effects of Gastrodia elata Blume water extract is related to gut microbiome remodeling in ApoE-/- mice exposed to unpredictable chronic mild stress. Journal of Ethnopharmacology, 2023;302(Pt B):115872. (IF=4.8, Rank: 9.3% INTEGRATIVE & COMPLEMENTARY MEDICINE)
-
2022Chen RA, Wu WK, Panyod S, Liu PY, Chuang HL, Chen YH, Lyu Q, Hsu HC, Lin TL, Shen TD, Yang YT, Zou HB, Huang HS, Lin YE, Chen CC, Ho CT, Lai HC, Wu MS, Hsu CC, Sheen LY. Dietary Exposure to Antibiotic Residues Facilitates Metabolic Disorder by Altering the Gut Microbiota and Bile Acid Composition. mSystems, 2022;28;7(3):e0017222. (IF=6.1, Rank: 18% MICROBIOLOGY) (Co-first author)
Chen RA, Wu WK, Panyod S, Liu PY, Chuang HL, Chen YH, Lyu Q, Hsu HC, Lin TL, Shen TD, Yang YT, Zou HB, Huang HS, Lin YE, Chen CC, Ho CT, Lai HC, Wu MS, Hsu CC, Sheen LY. Dietary Exposure to Antibiotic Residues Facilitates Metabolic Disorder by Altering the Gut Microbiota and Bile Acid Composition. mSystems, 2022;28;7(3):e0017222. (IF=6.1, Rank: 18% MICROBIOLOGY) (Co-first author)
-
2022Han DS, Wu WK, Liu PY, Yang YT, Hsu HC, Kuo CH, Wu MS, Wang TG. Differences in the gut microbiome and reduced fecal butyrate in elders with low skeletal muscle mass. Clinical Nutrition, 2022;41(7):1491-1500. (IF=6.7, Rank: 8.8% NUTRITION & DIETETICS) (Co-first author)
Han DS, Wu WK, Liu PY, Yang YT, Hsu HC, Kuo CH, Wu MS, Wang TG. Differences in the gut microbiome and reduced fecal butyrate in elders with low skeletal muscle mass. Clinical Nutrition, 2022;41(7):1491-1500. (IF=6.7, Rank: 8.8% NUTRITION & DIETETICS) (Co-first author)
-
2022Panyod S, Wu WK, Chen PC, Chong KV, Yang YT, Chuang HL, Chen CC, Chen RA, Liu PY, Chung CH, Huang HS, Lin AY, Shen TD, Yang KC, Huang TF, Hsu CC, Ho CT, Kao HL, Orekhov AN, Wu MS, Sheen LY. Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation. npj Biofilms and Microbiomes, 2022;27;8(1):4. (IF=8.0, Rank: 8.6% BIOTECHNOLOGY & APPLIED MICROBIOLOGY) (Co-first author)
Panyod S, Wu WK, Chen PC, Chong KV, Yang YT, Chuang HL, Chen CC, Chen RA, Liu PY, Chung CH, Huang HS, Lin AY, Shen TD, Yang KC, Huang TF, Hsu CC, Ho CT, Kao HL, Orekhov AN, Wu MS, Sheen LY. Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation. npj Biofilms and Microbiomes, 2022;27;8(1):4. (IF=8.0, Rank: 8.6% BIOTECHNOLOGY & APPLIED MICROBIOLOGY) (Co-first author)
-
2022Lee MC, Chen MJ, Huang HW, Wu WK, Lee YW, Kuo HC, Huang CC. Probiotic Lactiplantibacillus plantarum Tana Isolated from an International Weightlifter Enhances Exercise Performance and Promotes Antifatigue Effects in Mice. Nutrients, 2022;14(16):3308. (IF=4.8, Rank: 15.8% NUTRITION & DIETETICS)
Lee MC, Chen MJ, Huang HW, Wu WK, Lee YW, Kuo HC, Huang CC. Probiotic Lactiplantibacillus plantarum Tana Isolated from an International Weightlifter Enhances Exercise Performance and Promotes Antifatigue Effects in Mice. Nutrients, 2022;14(16):3308. (IF=4.8, Rank: 15.8% NUTRITION & DIETETICS)
-
2021Liao HY, Wang CY, Lee CH, Kao HL, Wu WK*, Kuo CH*. Development of an Efficient and Sensitive Chemical Derivatization-Based LC-MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease. Journal of Proteome Research, 2021;2;20(7):3508-3518. (IF=4.1, Rank: 17.6% BIOCHEMICAL RESEARCH METHODS) (Co-correspondence)
Liao HY, Wang CY, Lee CH, Kao HL, Wu WK*, Kuo CH*. Development of an Efficient and Sensitive Chemical Derivatization-Based LC-MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease. Journal of Proteome Research, 2021;2;20(7):3508-3518. (IF=4.1, Rank: 17.6% BIOCHEMICAL RESEARCH METHODS) (Co-correspondence)
-
2021Wu WK, Chen YH, Lee PC, Yang PJ, Chang CC, Liu KL, Hsu CC, Huang CC, Chuang HL, Sheen LY, Liu CJ, Wu MS. Mining Gut Microbiota from Bariatric Surgery for MAFLD. Frontiers in Endocrinology, 2021;9;12:612946. (IF=4.9, Rank: 27.4% ENDOCRINOLOGY & METABOLISM)
Wu WK, Chen YH, Lee PC, Yang PJ, Chang CC, Liu KL, Hsu CC, Huang CC, Chuang HL, Sheen LY, Liu CJ, Wu MS. Mining Gut Microbiota from Bariatric Surgery for MAFLD. Frontiers in Endocrinology, 2021;9;12:612946. (IF=4.9, Rank: 27.4% ENDOCRINOLOGY & METABOLISM)
-
2021Wu WK, Ivanova EA*, Orekhov AN*. Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer. Seminars in cancer biology, 2021;70:85-97. (IF=13.2, Rank: 6.5% ONCOLOGY)
Wu WK, Ivanova EA*, Orekhov AN*. Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer. Seminars in cancer biology, 2021;70:85-97. (IF=13.2, Rank: 6.5% ONCOLOGY)
-
2021Panyod S, Wu WK, Chen CC, Wu MS, Ho CT, Sheen LY. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases. Journal of Traditional and Complementary Medicine, 2021;13(2):107-118. (IF=3.3, Rank: 9.3% INTEGRATIVE & COMPLEMENTARY MEDICINE)
Panyod S, Wu WK, Chen CC, Wu MS, Ho CT, Sheen LY. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases. Journal of Traditional and Complementary Medicine, 2021;13(2):107-118. (IF=3.3, Rank: 9.3% INTEGRATIVE & COMPLEMENTARY MEDICINE)
-
2021Shen YC, Lee PC, Kuo YL, Wu WK, Chen CC, Lei CH, Yeh CP, Hsu C, Hsu CH, Lin ZZ, Shao YY, Lu LC, Liu TH, Chen CH, Wu MS, Huang YH, Cheng AL. An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, 2021;8:809-822. (IF=4.2, Rank: 27.6% ONCOLOGY)
Shen YC, Lee PC, Kuo YL, Wu WK, Chen CC, Lei CH, Yeh CP, Hsu C, Hsu CH, Lin ZZ, Shao YY, Lu LC, Liu TH, Chen CH, Wu MS, Huang YH, Cheng AL. An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, 2021;8:809-822. (IF=4.2, Rank: 27.6% ONCOLOGY)
-
2021Huang YJ, Choong LC, Panyod S, Lin YE, Huang HS, Lu KH, Wu WK, Sheen LY*. Gastrodia elata Blume water extract modulates neurotransmitters and alters the gut microbiota in a mild social defeat stress-induced depression mouse model. Phytotherapy Research, 2021;35(9):5133-5142. (IF=6.1, Rank: 9.7% CHEMISTRY, MEDICINAL)
Huang YJ, Choong LC, Panyod S, Lin YE, Huang HS, Lu KH, Wu WK, Sheen LY*. Gastrodia elata Blume water extract modulates neurotransmitters and alters the gut microbiota in a mild social defeat stress-induced depression mouse model. Phytotherapy Research, 2021;35(9):5133-5142. (IF=6.1, Rank: 9.7% CHEMISTRY, MEDICINAL)
-
2020Chen CC, Wu WK, Chang CM, Panyod S, Lu TP, Liou JM, Fang YJ, Chuang EY, Wu MS. Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles. Journal of the Formosan Medical Association, 2020;119(12):1791-1798. (IF=2.8, Rank: 21.5% MEDICINE, GENERAL & INTERNAL)
Chen CC, Wu WK, Chang CM, Panyod S, Lu TP, Liou JM, Fang YJ, Chuang EY, Wu MS. Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles. Journal of the Formosan Medical Association, 2020;119(12):1791-1798. (IF=2.8, Rank: 21.5% MEDICINE, GENERAL & INTERNAL)
-
2020Panyod S, Wu WK, Lu KH, Liu CT, Chu YL, Ho CT, Hsiao WW, Lai YS, Chen WC, Lin YE, Lin SH, Wu MS, Sheen LY*. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis Mice. Journal of Agricultural and Food Chemistry, 2020;68(10):3088-3098. (IF=6.0, Rank: 7.9% AGRICULTURE, MULTIDISCIPLINARY)
Panyod S, Wu WK, Lu KH, Liu CT, Chu YL, Ho CT, Hsiao WW, Lai YS, Chen WC, Lin YE, Lin SH, Wu MS, Sheen LY*. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis Mice. Journal of Agricultural and Food Chemistry, 2020;68(10):3088-3098. (IF=6.0, Rank: 7.9% AGRICULTURE, MULTIDISCIPLINARY)
-
2020Yeh CF, Chen YH, Liu SF, Kao HL, Wu MS, Yang KC*, Wu WK*. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis. International Journal of Molecular Sciences, 2020;21(22):8729. (IF=5.6, Rank: 21.1% BIOCHEMISTRY & MOLECULAR BIOLOGY) (Co-correspondence)
Yeh CF, Chen YH, Liu SF, Kao HL, Wu MS, Yang KC*, Wu WK*. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis. International Journal of Molecular Sciences, 2020;21(22):8729. (IF=5.6, Rank: 21.1% BIOCHEMISTRY & MOLECULAR BIOLOGY) (Co-correspondence)
-
2020Wu WK, Panyod S, Liu PY, Chen CC, Kao HL, Chuang HL, Chen YH, Zou HB, Kuo HC, Kuo CH, Liao BY, Chiu HT, Chung CH, Lin YC, Lee YC, Tang SL, Wang JT, Wu YW, Hsu CC, Sheen LY, Orekhov AN, Wu MS. Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery. Microbiome, 2020;19;8(1):162. (IF=17.9, Rank: 5.0% MICROBIOLOGY)
Wu WK, Panyod S, Liu PY, Chen CC, Kao HL, Chuang HL, Chen YH, Zou HB, Kuo HC, Kuo CH, Liao BY, Chiu HT, Chung CH, Lin YC, Lee YC, Tang SL, Wang JT, Wu YW, Hsu CC, Sheen LY, Orekhov AN, Wu MS. Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery. Microbiome, 2020;19;8(1):162. (IF=17.9, Rank: 5.0% MICROBIOLOGY)
-
2020Poznyak AV, Wu WK, Melnichenko AA, Wetzker R, Sukhorukov V, Markin AM, Khotina VA, Orekhov AN*. Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis. Cells, 2020;9(3):584. (IF=6.0, Rank: 30.7% CELL BIOLOGY)
Poznyak AV, Wu WK, Melnichenko AA, Wetzker R, Sukhorukov V, Markin AM, Khotina VA, Orekhov AN*. Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis. Cells, 2020;9(3):584. (IF=6.0, Rank: 30.7% CELL BIOLOGY)
-
2020Wu WK, Liou JM, Hsu CC, Lin YH, Wu MS*. Pandemic preparedness in Taiwan. Nature Biotechnology, 2020;38(8):932-933. (IF=56.9, Rank: 1.1% BIOTECHNOLOGY & APPLIED MICROBIOLOGY)
Wu WK, Liou JM, Hsu CC, Lin YH, Wu MS*. Pandemic preparedness in Taiwan. Nature Biotechnology, 2020;38(8):932-933. (IF=56.9, Rank: 1.1% BIOTECHNOLOGY & APPLIED MICROBIOLOGY)
-
2020Kirichenko TV, Markina YV, Sukhorukov VN, Khotina VA, Wu WK, Orekhov AN. A Novel Insight at Atherogenesis: The Role of Microbiome. Frontiers in Cell and Developmental Biology, 2020;8:586189. (IF=4.6, Rank: 12.8% DEVELOPMENTAL BIOLOGY)
Kirichenko TV, Markina YV, Sukhorukov VN, Khotina VA, Wu WK, Orekhov AN. A Novel Insight at Atherogenesis: The Role of Microbiome. Frontiers in Cell and Developmental Biology, 2020;8:586189. (IF=4.6, Rank: 12.8% DEVELOPMENTAL BIOLOGY)
-
2020Wu WK, Hsu CC, Sheen LY, Wu MS. Measurement of gut microbial metabolites in cardiometabolic health and translational research. Rapid Communications in Mass Spectrometry, 2020;34 Suppl 1:e8537. (IF=1.7, Rank: 65.1% CHEMISTRY, ANALYTICAL)
Wu WK, Hsu CC, Sheen LY, Wu MS. Measurement of gut microbial metabolites in cardiometabolic health and translational research. Rapid Communications in Mass Spectrometry, 2020;34 Suppl 1:e8537. (IF=1.7, Rank: 65.1% CHEMISTRY, ANALYTICAL)
-
2020Wu WK, Sheen LY, Wu MS. Response to the letter: Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful? Gut, 2020;69(3):610-611. (IF=24.5, Rank: 3.5% GASTROENTEROLOGY & HEPATOLOGY)
Wu WK, Sheen LY, Wu MS. Response to the letter: Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful? Gut, 2020;69(3):610-611. (IF=24.5, Rank: 3.5% GASTROENTEROLOGY & HEPATOLOGY)
-
2020Poznyak AV, Grechko AV, Orekhova VA, Chegodaev YS, Wu WK, Orekhov AN*. Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment. Biology (Basel), 2020;9(3):60. (IF=3.8, Rank: 18.3% BIOLOGY)
Poznyak AV, Grechko AV, Orekhova VA, Chegodaev YS, Wu WK, Orekhov AN*. Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment. Biology (Basel), 2020;9(3):60. (IF=3.8, Rank: 18.3% BIOLOGY)
-
2021Hsu YL, Chen CC, Lin YT, Wu WK, Chang LC, Lai CH, Wu MS, Kuo CH*. Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS. Journal of Proteome Research, 2019;18(5):1948-1957. (IF=4.1, Rank: 17.6% BIOCHEMICAL RESEARCH METHODS)
Hsu YL, Chen CC, Lin YT, Wu WK, Chang LC, Lai CH, Wu MS, Kuo CH*. Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS. Journal of Proteome Research, 2019;18(5):1948-1957. (IF=4.1, Rank: 17.6% BIOCHEMICAL RESEARCH METHODS)
-
2019Wu WK, Chen CC, Panyod S, Chen RA, Wu MS, Sheen LY, Chang SC. Optimization of fecal sample processing for microbiome study - The journey from bathroom to bench. Journal of the Formosan Medical Association, 2019;118(2):545-555. (IF=2.8, Rank: 21.5% MEDICINE, GENERAL & INTERNAL)
Wu WK, Chen CC, Panyod S, Chen RA, Wu MS, Sheen LY, Chang SC. Optimization of fecal sample processing for microbiome study - The journey from bathroom to bench. Journal of the Formosan Medical Association, 2019;118(2):545-555. (IF=2.8, Rank: 21.5% MEDICINE, GENERAL & INTERNAL)
-
2019Wu WK, Chen CC, Liu PY, Panyod S, Liao BY, Chen PC, Kao HL, Kuo HC, Kuo CH, Chiu THT, Chen RA, Chuang HL, Huang YT, Zou HB, Hsu CC, Chang TY, Lin CL, Ho CT, Yu HT, Sheen LY, Wu MS. Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice. Gut, 2019;68(8):1439-1449. (IF=24.5, Rank: 3.5% GASTROENTEROLOGY & HEPATOLOGY)
Wu WK, Chen CC, Liu PY, Panyod S, Liao BY, Chen PC, Kao HL, Kuo HC, Kuo CH, Chiu THT, Chen RA, Chuang HL, Huang YT, Zou HB, Hsu CC, Chang TY, Lin CL, Ho CT, Yu HT, Sheen LY, Wu MS. Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice. Gut, 2019;68(8):1439-1449. (IF=24.5, Rank: 3.5% GASTROENTEROLOGY & HEPATOLOGY)
-
2016Panyod S, Wu WK, Ho CT, Lu KH, Liu CT, Chu YL, Lai YS, Chen WC, Lin YE, Lin SH, Sheen LY. Diet Supplementation with Allicin Protects against Alcoholic Fatty Liver Disease in Mice by Improving Anti-inflammation and Antioxidative Functions. Journal of Agricultural and Food Chemistry, 2016;64(38):7104-13. (IF=6.0, Rank: 7.9% AGRICULTURE, MULTIDISCIPLINARY)
Panyod S, Wu WK, Ho CT, Lu KH, Liu CT, Chu YL, Lai YS, Chen WC, Lin YE, Lin SH, Sheen LY. Diet Supplementation with Allicin Protects against Alcoholic Fatty Liver Disease in Mice by Improving Anti-inflammation and Antioxidative Functions. Journal of Agricultural and Food Chemistry, 2016;64(38):7104-13. (IF=6.0, Rank: 7.9% AGRICULTURE, MULTIDISCIPLINARY)
-
2015Wu WK, Panyod S, Ho CT, Kuo CH, Wu MS, Sheen LY*. Dietary allicin reduces transformation of L-carnitine to TMAO through impact on gut microbiota. Journal of Functional Foods, 2015;15: 408-417. (IF=3.8, Rank: 30.7% NUTRITION & DIETETICS)
Wu WK, Panyod S, Ho CT, Kuo CH, Wu MS, Sheen LY*. Dietary allicin reduces transformation of L-carnitine to TMAO through impact on gut microbiota. Journal of Functional Foods, 2015;15: 408-417. (IF=3.8, Rank: 30.7% NUTRITION & DIETETICS)